Sarah Gensheimer

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

Clinical Cancer Research · 2020 · First of 13 authors · 250 citations

Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy

JCI Insight · 2019 · 217 citations